3-aminobenzamide has been researched along with Experimental Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (75.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zhu, Q | 1 |
Wang, X | 1 |
Chu, Z | 1 |
He, G | 1 |
Dong, G | 1 |
Xu, Y | 1 |
Brown, DM | 1 |
Horsman, MR | 1 |
Hirst, DG | 1 |
Brown, JM | 1 |
Yamamoto, H | 1 |
Okamoto, H | 1 |
Pan, QC | 1 |
Guo, HY | 1 |
4 other studies available for 3-aminobenzamide and Experimental Neoplasms
Article | Year |
---|---|
Design, synthesis and biological evaluation of novel imidazo[4,5-c]pyridinecarboxamide derivatives as PARP-1 inhibitors.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Dose- | 2013 |
Enhancement of melphalan cytotoxicity in vivo and in vitro by inhibitors of poly (ADP-ribose) polymerase.
Topics: Animals; Benzamides; Caffeine; Cell Line; Cell Survival; Cricetinae; Cricetulus; Dose-Response Relat | 1984 |
Poly(ADP-ribose) synthetase inhibitors enhance streptozotocin-induced killing of insulinoma cells by inhibiting the repair of DNA strand breaks.
Topics: Adenoma, Islet Cell; Animals; Benzamides; Cell Line; Cell Survival; Cricetinae; DNA Repair; Insulino | 1982 |
The potentiation of the antitumor activity but not toxicity of bleomycin by 3-aminobenzamide.
Topics: Animals; Benzamides; Bleomycin; Body Weight; Dose-Response Relationship, Drug; Drug Synergism; Hydro | 1989 |